Malaria vaccines

Medical Journal of Australia

Volumn 177, Issue 5, 2002, Pages 230-231

  Brown, Graham V ^a   Reeder, John C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; MALARIA VACCINE;

CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; ERADICATION THERAPY; FINANCIAL MANAGEMENT; HEALTH CARE FACILITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; MALARIA; MALARIA CONTROL; MORTALITY; NONHUMAN; OUTPATIENT; PARASITE;

EID: 0037009448     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04752.x     Document Type: Editorial

References (8)

1. The ears of the hippopotamus: Manifestations, determinants and estimates of the malaria burden
2. Towards a malaria vaccine for Papua New Guinea
3. The Abuja Declaration on Roll Back Malaria in Africa. Abjura, Nigeria, 25 April
4. Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine
5. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in the Gambia: A randomised trial
6. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea
7. Australia's preeminent malaria scientists to collaborate with the Malaria Vaccine Initiative. Three new projects pursue promising candidate vaccines